| dc.contributor.author | Rappazzo, C Garrett | |
| dc.contributor.author | Huisman, Brooke D | |
| dc.contributor.author | Birnbaum, Michael E | |
| dc.date.accessioned | 2021-10-27T20:31:03Z | |
| dc.date.available | 2021-10-27T20:31:03Z | |
| dc.date.issued | 2020 | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/136143 | |
| dc.description.abstract | © 2020, The Author(s). CD4+ helper T cells contribute important functions to the immune response during pathogen infection and tumor formation by recognizing antigenic peptides presented by class II major histocompatibility complexes (MHC-II). While many computational algorithms for predicting peptide binding to MHC-II proteins have been reported, their performance varies greatly. Here we present a yeast-display-based platform that allows the identification of over an order of magnitude more unique MHC-II binders than comparable approaches. These peptides contain previously identified motifs, but also reveal new motifs that are validated by in vitro binding assays. Training of prediction algorithms with yeast-display library data improves the prediction of peptide-binding affinity and the identification of pathogen-associated and tumor-associated peptides. In summary, our yeast-display-based platform yields high-quality MHC-II-binding peptide datasets that can be used to improve the accuracy of MHC-II binding prediction algorithms, and potentially enhance our understanding of CD4+ T cell recognition. | en_US |
| dc.language.iso | en | |
| dc.publisher | Springer Science and Business Media LLC | en_US |
| dc.relation.isversionof | 10.1038/S41467-020-18204-2 | en_US |
| dc.rights | Creative Commons Attribution 4.0 International license | en_US |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_US |
| dc.source | Nature | en_US |
| dc.title | Repertoire-scale determination of class II MHC peptide binding via yeast display improves antigen prediction | en_US |
| dc.type | Article | en_US |
| dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Biological Engineering | |
| dc.contributor.department | Ragon Institute of MGH, MIT and Harvard | |
| dc.relation.journal | Nature Communications | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dc.date.updated | 2021-08-25T14:25:35Z | |
| dspace.orderedauthors | Rappazzo, CG; Huisman, BD; Birnbaum, ME | en_US |
| dspace.date.submission | 2021-08-25T14:25:36Z | |
| mit.journal.volume | 11 | en_US |
| mit.journal.issue | 1 | en_US |
| mit.license | PUBLISHER_CC | |
| mit.metadata.status | Authority Work and Publication Information Needed | |